Part of funding portal member: truCrowd, Inc.
Mobile Menu
truCrowd - Equity Crowdfunding

AphriHelios Global, LLC

Leveraging Africa's low-production cost advantage to build a vertically integrated cannabis company bringing African and African diaspora brands to the world
INVEST

Minimum target reached
(accepting oversubscriptions)

63dd16hh

Time left to invest


$32,700

amount committed 

$10k - $107k

funding goal 

Regulation CF

exemption used 

$18,563,000

pre money valuation 

$250.00

min investment 

44

investors 


Security Type
Convertible Note
Annual Interest Rate: 8%
Discount Rate: 20%
Valuation Cap: $15M
Term: 2 years
Bonus

Early Bird Bonus!

Investors who purchase the first 1,000 Units of Convertible Notes will receive an additional 15% Preferred Shares at conversion in a Qualified Equity Financing.

 

Volume Bonus!

Based on the size of your investment, you can also get bonus shares regardless of if you are an “early bird” investor or not! Early bird investors get both bonus percentages added together (an early bird investment of $5,000 would receive a 25% bonus, 10%+15%)


$5,000+ - 10% additional Conversion Shares
$10,000+ - 12.5% additional Conversion Shares
$20,000+ - 15% additional Conversion Shares
$50,000+ - 25% additional Conversion Shares

Who are we

AphriHelios seeks to become a pan-African, vertically integrated medicinal cannabis company by leveraging Africa’s, and particularly Lesotho’s, comparative advantage as a low-cost producer. Warm climates, rich soil, and a long history and expertise in agriculture mean parts of the African continent have the potential to be pivotal markets for cultivation.

 

The cannabis industry is exploding and is likely to grow even faster in the US as recent political shifts will likely lead to decriminalization and legalization at the federal level. This shift will open up the US market for AphriHelios to import, at scale, African-grown, high-quality, low-production-cost cannabis. 

 

AphriHelios will vertically integrate through a phased approach that allows the company to sustainably migrate down the value chain. The company will cement its position as a high-quality, low-cost producer while building an innovative and exciting product and brand platform that build brands and products around well-known cultural, social, sports, and entertainment influencers. 

 

Updates

Darin Hickman
Darin Hickman2 months ago

As our way of thanking our investors, we're launching Investor Perks:

Early Bird Perk

Investors who purchase the first 1,000 Units of Convertible Notes will receive an additional 15% Preferred Shares at conversion in a Qualified Equity Financing.

Volume Perks

$5,000 - $9,999 – 10% additional Preferred Shares at conversion in a Qualified Equity Financing

$10,000 - $19,999 – 12.5% additional Preferred Shares at conversion in a Qualified Equity Financing

$20,000 - $49,999 – 15% additional Preferred Shares at conversion in a Qualified Equity Financing

$50,000+ – 25% additional Preferred Shares at conversion in a Qualified Equity Financing

Load More

Q&A


You must be logged in to be able to post a question.


Documents

Start-up Valuation Download
Offering Memorandum Download

Other Disclosures

Read the Form C filed with the SEC for other important disclosures, like financial statements, Directors, Officers, shareholders with more than 20% of voting rights, and more.
Use of Proceeds
The allocation of the use of proceeds among the categories of anticipated expenditures represents management’s best estimates based on the current status of the Company’s proposed operations, plans, investment objectives, capital requirements, and financial conditions. Future events, including changes in economic or competitive conditions of our business plan or the completion of less than the total Offering, may cause the Company to modify the above-described allocation of proceeds. The Company’s use of proceeds may vary significantly in the event any of the Company’s assumptions prove inaccurate. We will retain broad discretion in the allocation of the net proceeds from this Offering, reserve the right to change the allocation of net proceeds from the Offering as unanticipated events or opportunities arise and could utilize the proceeds in ways that do not necessarily improve our results of operations or enhance the value of our Common Stock. Additionally, the Company may from time to time need to raise more capital to address future needs that we may not have anticipated as of the date of this Offering Circular.
Special Note Regarding Forward-Looking Statements
This offering contains forward-looking statements within the meaning of the federal securities laws. We caution investors that any forward-looking statements presented in this offering, or which management may make orally or in writing from time to time, are based on the Company’s beliefs and assumptions made by, and information currently available to, the Company. When used, the words “anticipate,” “believe,” “expect,” “intend,” “may,” “might,” “plan,” “estimate,” “project,” “should,” “will,” “would,” “result” and similar expressions, which do not relate solely to historical matters, are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties and factors that are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. While forward-looking statements reflect the Company’s good faith belief when made, they are not guarantees of future performance. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.
up

Back to top